An 81-year-old man with a history of carpal tunnel syndrome, diabetes mellitus, and nonmelanoma skin cancer presented with a 1-year history of an asymptomatic 4 mm diameter subcutaneous nodule on the right anterior scalp. A pilar cyst was suspected and an excisional biopsy was performed. Microscopic examination revealed extensive dermal infiltration by amorphous hyaline and fibrillary material (Figures 1-3) revealing the diagnosis of amyloidosis.
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of 290 PLCA cases at initial diagnosis, only 4 went on to develop systemic amyloidosis [3] . In their own retrospective institutional study identifying cases of localized nodular amyloidosis, 0 of the 20 patients went on to develop systemic disease over a 7.6-year mean follow-up period [3] .
Though it can be PLCA, which is relatively benign and requires only routine monitoring, nodular amyloidosis can also be the presenting sign of a serious systemic pathology, such as systemic AL amyloidosis in this case. Systemic AL amyloidosis has a reported incidence of only 3 to 5 cases per million population, correlating to roughly 1 750 to 3 200 new cases annually in the United States [8, 9] . Cutaneous involvement occurs in up to 29% to 40% of cases [10] . 
Discussion
Amyloidosis is not just one disease but a rare group of diseases resulting from the extracellular deposition of misfolded proteins in various tissues as toxic amyloid aggregates. Amyloidosis is characterized based on the subtype of amyloid fibril protein as well as the mechanism of deposition. Cutaneous amyloidosis may be organized into one of 3 groups: primary localized cutaneous amyloidosis (PLCA), secondary localized cutaneous amyloidosis, or systemic AL amyloidosis with cutaneous involvement [1] . Among the PLCA group, lichen, macular, biphasic, and nodular forms are recognized.
The most encountered type of PLCA, lichen amyloidosis, presents clinically as multiple hyperpigmented, clustered, pruritic papules on the lower extremities [2] . Macular amyloidosis presents darkly pigmented macules with a rippled surface.
Both lichen and macular types are derived from cytokeratins [2] . The biphasic form is simply a mix of the macular and lichen amyloidoses.
Nodular amyloidosis, accounting for 1.5% of PLCA cases, presents as either single or multiple lesions and is derived from immunoglobulins, commonly lambda light chain. There have been less than 100 cases of primary localized nodular amyloidosis reported to date [2] [3] [4] [5] . Some studies suggest that nodular amyloidosis may be associated with systemic disease in 7% to 50% of patients [6, 7] . However, a literature review conducted by Biewend et al found that biopsy is done to monitor for monoclonal plasma cells and if present, requires further evaluation to determine whether the patient has active multiple myeloma [15] . Aspiration of subcutaneous tissues of the abdominal wall or of an involved organ (in our patient, the skin) is required to definitively confirm the diagnosis of systemic amyloidosis [16] . Because primary nodular amyloidosis has a significant association with Sjögren syndrome, serology for ANA, anti-Ro/SSA, and anti-La/SSB may also be considered, which in this case were unremarkable [17] [18] [19] . lary and reticular dermis as well as in the subcutaneous fat [11] . Flattened rete ridges may be observed in the overlying epidermis. Amyloids stained with Congo red display applegreen birefringence under polarized light. Because nodular amyloid is produced by plasma cell infiltration, specimens may stain with immunohistochemical stains for kappa or lambda chains [11] .
Conclusions
It is common for cysts to be falsely diagnosed based on appearance alone. One retrospective analysis aimed to see if histological findings correlated with clinical diagnosis. The authors found that 13 of 295 cases were positive for calcium deposition, described as calcinosis cutis, on histology [12] .
These findings compromised all the cases under the deposition category: no cases of amyloid deposition were evident.
This highlights the rarity of nodular amyloidosis mimicking a cystic lesion. Investigation of a benign-appearing subcutaneous nodule as the initial presentation for asymptomatic AL amyloidosis in a relatively healthy patient is atypical, as the diagnosis is often made after workup of unexplained cardiomyopathy, proteinuria, neuropathy, or hepatomegaly. It is difficult to determine the precise occurrence of this presentation given the limited number of cases in the literature.
Importantly, since nodular primary cutaneous amyloidosis is so rare, biopsy-confirmed amyloid lesions warrant further workup as immunoglobulin light-chain amyloid fibrils may be a complication of systemic and multiple myeloma-associated amyloidosis [13] . Therefore, evaluation for systemic involvement at the time of diagnosis is recommended. Plasma [14] . The presence of a monoclonal protein is found in 80% to 90% of serum and urine immunochemistry studies in patients with primary amyloidosis [15] . Bone marrow
